Skip to main content
Clinical Trials/NCT04749342
NCT04749342
Completed
Not Applicable

Complete Decongestive Therapy Versus Compression Bandaging in Advanced Secondary Lymphedema

Ahmed Mohamed Abdelrauf1 site in 1 country60 target enrollmentStarted: March 1, 2019Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Ahmed Mohamed Abdelrauf
Enrollment
60
Locations
1
Primary Endpoint
Limb Volume

Overview

Brief Summary

The purpose of this study is to:

Find out the efficacy of using complete decongestive physiotherapy on limb volume in advanced secondary upper and lower extremity lymphedema patients.

Find out the efficacy of compression bandaging on limb volume in advanced lymphedema patients.

This study was conducted to compare between the efficacy of complete decongestive therapy (CDT) and compression bandaging in advanced secondary lower extremity lymphedema.

Detailed Description

The study was conducted at the department of plastic surgery, Kasr Al-Ainy hospital. Sixty patients of both genders aged from 40 to 55 years old were participated in this study, and they were randomly assigned to two study groups.

Group I: Thirty patients received CDT (60 min of manual lymph drainage MLD, compression bandaging, exercises, and skin care).

Group II: Thirty patients received compression bandaging alone. The same bandaging scheme used for both groups. The therapy included 12 interventions performed 5 days a week, during the first two weeks in addition to another successive two sessions at the third week, i.e., for a total of twelve sessions.

Evaluation of limb volume using water volumetry and 4-cm truncated cone circumferential measurements were done before treatment application, after 6 sessions (post 1) and after 12 sessions (post 2).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
40 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with lower limb lymphedema (stage II and III) secondary lymphedema aged from 40 to 55 years old, with BMI less than 35 and duration of illness ranged from 3-9 years were included in the study

Exclusion Criteria

  • the patients were excluded if they have acute erysipelas, acute thrombophlebitis phlebothrombosis and decompensated heart failure.

Outcomes

Primary Outcomes

Limb Volume

Time Frame: 1 Month

girth Limb Measurement

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Ahmed Mohamed Abdelrauf
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Ahmed Mohamed Abdelrauf

Complete Decongestive Therapy Versus Compression Bandaging in Advanced Secondary Lymphedema

Cairo University

Study Sites (1)

Loading locations...

Similar Trials